GSK announces Phase III data for TYKERB/TYVERB® (lapatinib) in combination with chemotherapy for advanced HER2-positive gastric cancer
3 June 2013 | By GlaxoSmithKline
Study did not meet the primary endpoint...
List view / Grid view
News
Novartis breakthrough therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
3 June 2013 | By Novartis
Novartis announced data on its investigational compound LDK378...
Abbott previews next-generation blood screening prototype during International Society of Blood Transfusion Meeting
3 June 2013 | By Abbott
New solution underscores Abbott’s continued commitment to ensuring the safety of the blood supply...
Merck announces presentation of interim data from study evaluating Lambrolizumab
2 June 2013 | By Merck
Merck expands Lambrolizumab clinical development program...
Roche’s medicine Avastin plus chemotherapy improved survival in women with advanced cervical cancer, compared to chemotherapy alone
2 June 2013 | By Roche
Results of study GOG240...
Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor growth in HER2 positive advanced breast cancer
2 June 2013 | By Novartis
Results from a pivotal Phase III trial...
Bristol-Myers Squibb announces Phase 1 results from first trial combining immune checkpoint inhibitors
2 June 2013 | By Bristol-Myers Squibb Company
Results from Study 004...
Roche announces final phase III study results of Avastin plus radiotherapy and chemotherapy in people with an aggressive form of brain cancer
1 June 2013 | By Roche
Final results from the phase III AVAglio study...
GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer
1 June 2013 | By GlaxoSmithKline
GSK announced that its Phase III clinical trial of VOTRIENT...
Amgen presents positive results from talimogene laherparepvec Phase 3 study in patients with metastatic melanoma
1 June 2013 | By Amgen
Amgen announced detailed results from a pivotal Phase 3 trial...
Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study
1 June 2013 | By Boehringer Ingelheim
Data from Boehringer Ingelheim’s LUX-Lung 6 trial...
Experts call for breast cancer trials aimed at younger patients
31 May 2013 | By Cancer Research UK
A LACK of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates...
INCIVO® (telaprevir) receives European Commission approval
31 May 2013 | By Daniel J Edelman Ltd
The EC has approved a new twice daily dosing of INCIVO® (telaprevir)...
Novo Nordisk files for regulatory approval of IDegLira in the EU for the treatment of type 2 diabetes
31 May 2013 | By Novo Nordisk
Novo Nordisk announced the submission to the EMA of the MAA for the approval of IDegLira...
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
30 May 2013 | By Teva Pharmaceutical Industries Ltd.
"We are pleased that the FDA has accepted for review our sNDA..."
